Hypofractionated Radiotherapy with Temozolomide and Bevacizumab in Glioblastoma: Phase II Trial Results

Purpose: Bevacizumab is associated with decreased vascular permeability that allows for more aggressive radiotherapy schedules. We conducted a phase II trial in newly diagnosed glioblastoma utilizing a novel hypofractionated stereotactic radiotherapy...